search results for

refine results

sort by

Date
Relevance

result type

Articles
Video

Wires
Press Releases

Retail stocks rise as border-adjustment tax fears diminish

The SPDR S&P Retail ETF (XRT) climbed more than 1.5 percent, led by shares of Michaels.

Source: CNBC.com

US rally is running out of steam: ETF Securities

James Butterfill, head of research & investment strategy at ETF Securities, takes a look at market performance, especially with Brexit talks and Trump inauguration on the horizon.

Source: CNBC.com

Final Trade: EEM, NVDA & more

The "Fast Money" traders reveal their final trades including iShares MSCI Emerging Markets ETF EEM, Nvidia and more.

Source: CNBC.com

Unusual activity: Bulls pile into silver (SLV)

"Fast Money Halftime Report" trader Pete Najarian discusses unusual options activity in the iShares Silver Trust ETF SLV.

Source: CNBC.com

Trump says drugmakers are 'getting away with murder,' and biotech stocks plunge

The iShares Nasdaq Biotechnology ETF (IBB) briefly fell more than 2.5 percent, tracking for its first negative day of 2017.

Source: CNBC.com

Can airline stocks keep soaring to new heights?

The "Fast Money" traders discuss the trade on airlines, with the XAL ETF up more than 2 percent.

Source: CNBC.com

A bitcoin ETF would have 'very significant upside' — but it probably won't happen: Analyst

Followers are assigning too high a likelihood that regulators will OK a bitcoin ETF proposed by Tyler and Cameron Winklevoss, according to one analyst.

Source: CNBC.com

Final Trade: BMY, FXI & more

The "Fast Money" traders share their final trades of the day, including Bristol-Myers Squibb, iShares China Large-Cap ETF FXI and more.

Source: CNBC.com

Retail sector tanks as Macy's and Kohl's get crushed by weak holiday sales

The SPDR S&P Retail ETF (XRT) dropped more than 3 percent, weighed down by sharp losses from Macy's and Kohl's.

Source: CNBC.com

Betting on biotech during JPMorgan's big health-care conference pays off, history shows

Buying the biotech ETF during JPMorgan's annual health-care conference has proven to be a profitable trade, according to research by the investment bank.

Source: CNBC.com